The NP ZORA organised by the Institute of Oncology Ljubljana in cooperation with the Ministry of Health and the Health Insurance Institute of Slovenia, was implemented in 2003 with conventional cytology in three-year screening intervals in the 20–64 age group. The three-year coverage of the target population with a screening test is just above 70%, and its five-year coverage is just above 80%. Higher coverage is observed in younger women and reaches 80% in the 20–24 age group. It drops below 70% in women above 50 and is just below 55% in the oldest age group of women aged from 60 to 64. Coverage also varies between administrative units. Slovenia is among the European countries with the highest historical cervical cancer incidence rates but is also among the countries with the most pronounced decline in cervical cancer incidence rates over time. The steepest decline was observed after the implementation of the NP ZORA, in 2003‒2015, with the annual percentage change being ‒5.8. Non-attenders in the NP ZORA account for 50‒60% of new cervical cancer cases, among which more than 80% are diagnosed at FIGO stage II or higher, compared to regular attenders where only 20% of cancers are diagnosed at stage II or higher.